Bioblast Pharma Ltd. (extinct)

Bioblast Pharma Ltd. (extinct)

Bioblast Pharma Ltd. (extinct)

Overview
Date Founded

2012

Headquarters

37 Dereh Menachem Begin Street,15th Floor,Tel Aviv 6522042

Type of Company

Public

Employees (Worldwide)

11 - 50

Industries

Biotechnology
Retail: Drug Stores
Pharmaceuticals

Company Description

Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel.

Executives & Employees

Director-Regulatory Affairs

Paths to Bioblast Pharma Ltd.
Potential Connections via
Relationship Science
You
Bioblast Pharma Ltd.
Recent Transactions
Details Hidden

Bioblast Pharma Ltd. purchases Enlivex Therapeutics Ltd. from Korea Investment Partners Co., Ltd., Pontifax Management Co. Ltd., Hadasit Bio-Holdings Ltd. (Private Equity)

Details Hidden

Bioblast Pharma Ltd. raised money in a private placement transaction

Details Hidden

Bioblast Pharma Ltd. issued Ordinary Shares

Transaction Advisors
Underwriter

Advised onBioblast Pharma Ltd. issued Ordinary Shares

Investment Advisor

Advised onBioblast Pharma Ltd. raised money in a private placement transaction

Underwriter

Advised onBioblast Pharma Ltd. issued Ordinary Shares

Advisors & Consultants
Advisor

Founding Partner at LifeSci Capital LLC

Investors
Details Hidden

Pontifax is a long-term, active manager which invests in Israeli companies in the life sciences sector. The firm generally takes a seat on the board of directors of their investee companies.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bioblast Pharma Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bioblast Pharma Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Bioblast Pharma Ltd..